Clinical trial
Codeine in Sickle Cell Disease
NCT00174538 · PriCara, Unit of Ortho-McNeil, Inc., Industry · Completed
Key facts
| NCT number | NCT00174538 |
|---|---|
| Title | Codeine in Sickle Cell Disease |
| Official title | The Effects of Cytochrome P450 2D6 Genotype on Pain Management With Codeine in Sickle Cell Disease |
| Lead sponsor | PriCara, Unit of Ortho-McNeil, Inc., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Sickle Cell Disease |
| Intervention type | Drug |
| Interventions | Codeine (30 mg) |
| Enrollment | 60 |
| Start date | Mar 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 30, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: